SCHEMBL8619346

SCHEMBL8619346

COc1ccc2c(NC(=N)NC=O)cc(-c3ccccc3C)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 7/20 0.46
CA2 P00918 3/20 0.44
CA9 Q16790 3/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 1/20 0.44
MAPT P10636 2/20 0.40
THRB P10828 1/20 0.40
NQO2 P16083 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
IGF1R P08069 1/20 0.38
CYP2C9 P11712 2/20 0.37
CYP2D6 P10635 1/20 0.37
PKM P14618 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616673 0.92 CA2 (0.50) TACR3CA2CA9CA12CA1
SCHEMBL8613990 0.90 TACR3 (0.39) TACR3CA2CA9CA12CA1
SCHEMBL8613388 0.89 SMN1; SMN2 (0.39) TACR3CA2CA9CA12CA1
SCHEMBL8615511 0.88 TACR3 (0.35) TACR3CA2CA9CA12CA1
SCHEMBL8615853 0.87 TACR3 (0.37) TACR3CA2CA9CA12CA1
SCHEMBL8615573 0.87 TACR3 (0.37) TACR3CA2CA9CA12CA1
SCHEMBL8617890 0.87 MEN1 (0.45) TACR3CA2CA9CA12CA1
SCHEMBL8616497 0.87 TACR3 (0.61) TACR3MAPTNQO2KDM4EALDH1A1
SCHEMBL8620107 0.87 HTT (0.37) TACR3CA2CA9CA12CA1
SCHEMBL8620892 0.86 HTT (0.47) TACR3MAPTKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed